Skip to main content
Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
0.5281
-0.0885 (-14.35%)
At close: Nov 13, 2026, 4:00 PM EST
0.5349
+0.0068 (1.29%)
After-hours: Nov 13, 2026, 6:16 PM EST

CELZ Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
00.010.010.010.090.09
Revenue Growth
-50.00%-45.45%22.22%-89.84%0.96%-46.65%
Cost of Revenue
00000.030.05
Gross Profit
000.010.010.060.04
Selling, General & Admin
4.443.763.243.563.942.96
Research & Development
3.152.262.41.976.270.11
Amortization of Goodwill & Intangibles
0.10.120.110.090.090.09
Operating Expenses
7.76.155.755.6310.33.17
Operating Income
-7.69-6.14-5.74-5.62-10.24-3.13
Interest Expense
------4.28
Interest & Investment Income
0.230.150.250.330.1-
Other Non Operating Income (Expenses)
-----26.03
EBT Excluding Unusual Items
-7.47-6-5.49-5.29-10.1418.63
Other Unusual Items
-----0.59
Pretax Income
-7.47-6-5.49-5.29-10.1419.21
Net Income
-7.47-6-5.49-5.29-10.1419.21
Net Income to Common
-7.47-6-5.49-5.29-10.1419.21
Net Income Growth
------
Shares Outstanding (Basic)
421110
Shares Outstanding (Diluted)
421110
Shares Change
86.19%60.95%5.17%28.76%236.51%460.63%
EPS (Basic)
-1.81-2.52-3.71-3.76-9.2873.75
EPS (Diluted)
-1.82-2.52-3.71-3.76-9.2856.10
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
66.87%63.43%60.00%60.00%67.84%45.36%
Operating Margin
-256435.00%-102380.23%-52216.92%-62445.91%-11562.50%-3562.17%
Profit Margin
-249160.10%-99916.80%-49940.74%-58739.71%-11449.26%21892.76%
EBITDA
-7.63-6.02-5.63-5.53-10.15-3.03
D&A For EBITDA
0.060.120.110.090.090.09
EBIT
-7.69-6.14-5.74-5.62-10.24-3.13
SEC Filings: 10-K · 10-Q